We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
+7.92%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$203B
AUM Growth
+$28.4B
Cap. Flow
+$14B
Cap. Flow %
6.91%
Top 10 Hldgs %
26.11%
Holding
7,181
New
869
Increased
2,214
Reduced
2,337
Closed
1,192

Sector Composition

Rank Sector Weight
1 Technology 8.37%
2 Healthcare 7.45%
3 Consumer Discretionary 5.14%
4 Industrials 5.1%
5 Financials 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NFNT.WS
5426
CALL
DELISTED
Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFNT.WS
$44.9K ﹤0.01%
337,500
ALYA
5427
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
$44.8K ﹤0.01%
+27,479
New +$50.7K
LSF icon
5428
Laird Superfood
LSF
$46.2M
$44.1K ﹤0.01%
55,471
-30,681
-36% -$26.2K
WEL.WS
5429
CALL
DELISTED
Integrated Wellness Acquisition Corp Redeemable Warrants
WEL.WS
$44.1K ﹤0.01%
52,500
VRAY
5430
CALL
DELISTED
ViewRay, Inc.
VRAY
$44K ﹤0.01%
125,000
-275,000
-69% -$285K
TLIS
5431
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$43.9K ﹤0.01%
6,098
-4,813
-44% -$34.9K
RPID icon
5432
Rapid Micro Biosystems
RPID
$105M
$43.8K ﹤0.01%
43,772
+8,715
+25% +$8.81K
GLMD icon
5433
Galmed Pharmaceuticals
GLMD
$4.95M
$43.4K ﹤0.01%
1,242
+511
+70% +$27.6K
KRNLW
5434
CALL
DELISTED
Kernel Group Holdings, Inc. Warrants
KRNLW
$43.2K ﹤0.01%
370,500
XHG
5435
XChange TEC
XHG
$50.5M
$42.6K ﹤0.01%
9
-7
-44% -$63K
PLX icon
5436
Protalix BioTherapeutics
PLX
$183M
$42.5K ﹤0.01%
21,232
-65,466
-76% -$156K
IVCPW
5437
CALL
DELISTED
Swiftmerge Acquisition Corp. Warrants
IVCPW
$42K ﹤0.01%
401,121
ALLG
5438
CALL
DELISTED
Allego N.V.
ALLG
$41.7K ﹤0.01%
+143,670
New +$325K
ARBE icon
5439
Arbe Robotics
ARBE
$73.6M
$41.5K ﹤0.01%
+14,349
New +$35.7K
SES.WS icon
5440
CALL
SES AI Corp Warrants
SES.WS
$3.65M
$41.3K ﹤0.01%
133,333
PSQH.WS icon
5441
CALL
PSQ Holdings, Inc. Warrants, Each whole warrant exercisable for 1/15th of a share of Class A common stock at an exercise price of $172.50 per share
PSQH.WS
$1.63M
$41.3K ﹤0.01%
53,780
-7,333
-12% -$2.5K
ZYNE
5442
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$41K ﹤0.01%
125,835
-330,514
-72% -$118K
IDN icon
5443
Intellicheck
IDN
$74.5M
$40.8K ﹤0.01%
16,533
-19,454
-54% -$47.1K
SYRS
5444
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$40.4K ﹤0.01%
12,825
-65,511
-84% -$211K
TFFP
5445
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$40.1K ﹤0.01%
3,410
-4,460
-57% -$64.1K
OCFT
5446
DELISTED
OneConnect Financial Technology
OCFT
$40K ﹤0.01%
12,117
-54,889
-82% -$253K
CDAQW
5447
CALL
DELISTED
Compass Digital Acquisition Corp. Warrant
CDAQW
$39.8K ﹤0.01%
267,617
LMDX
5448
DELISTED
LumiraDx Limited Common Shares
LMDX
$39.8K ﹤0.01%
82,907
-41,112
-33% -$21.4K
AONCW
5449
CALL
DELISTED
American Oncology Network, Inc. Warrant
AONCW
$39.6K ﹤0.01%
256,890
FZT.WS
5450
CALL
DELISTED
FAST Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
FZT.WS
$39.3K ﹤0.01%
56,250

Similar funds

Millennium Management's Q2 2023 Portfolio in Review

As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.

By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.

  • Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
  • Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
  • Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
  • Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
  • Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
  • Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
  • Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.